Assessment of the ferret as an in vivo model for mumps virus infection

References

1. Afzal M. A., Dussupt V., Minor P. D., Pipkin P. A., Fleck R., Hockley D. J., Stacey G. N. 2005; Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations. J Virol Methods 126:149–156 [View Article][PubMed]
   [Google Scholar]
2. Andrewes C. H., Bang F. B., Burnet F. M. 1955; A short description of the Myxovirus group (influenza and related viruses). Virology 1:176–184 [View Article][PubMed]
   [Google Scholar]
3. Binder G. K., Griffin D. E. 2001; Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293:303–306 [View Article][PubMed]
   [Google Scholar]
4. Bossert B., Conzelmann K. K. 2002; Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76:4287–4293 [View Article][PubMed]
   [Google Scholar]
5. Carbone K. M., Rubin S. 2007; Mumps virus. In Fields Virology, 6th edn. pp. 1527–1550 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott, Williams and Wilkins;
   [Google Scholar]
6. Chu L. W., Morgan H. R. 1950; Studies of the hemolysis of red blood cells by mumps virus: II. The relationships of hemagglutination, virus elution, and hemolysis. J Exp Med 91:403–416 [View Article][PubMed]
   [Google Scholar]
7. Cohen B. J., Audet S., Andrews N., Beeler J., Red W. W. G. M. P.WHO working group on measles plaque reduction neutralization test 2007; Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26:59–66 [View Article][PubMed]
   [Google Scholar]
8. Enders J. F., Kane L. W., Cohen S., Levens J. H. 1945; Immunity in mumps I. Experiments with monkeys (Macacus mulatta). The development of complement-fixing antibody following infection and experiments on immunization by means of inactivated virus and convalescent human serum. J Exp Med 81:93–117 [View Article][PubMed]
   [Google Scholar]
9. Ferm V. H., Kilham L. 1963; Mumps virus infection of the pregnant hamster. J Embryol Exp Morphol 11:659–665[PubMed]
   [Google Scholar]
10. Gordon I., Pavri K., Cohen S. M. 1956; Response of ferrets to mumps virus. J Immunol 76:328–333[PubMed]
    [Google Scholar]
11. Houard S., Varsanyi T. M., Milican F., Norrby E., Bollen A. 1995; Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J Gen Virol 76:421–423 [View Article][PubMed]
    [Google Scholar]
12. Ichiyama T., Maeba S., Suenaga N., Saito K., Matsubara T., Furukawa S. 2005; Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: comparison with echovirus type 30 meningitis. Cytokine 30:243–247 [View Article][PubMed]
    [Google Scholar]
13. Johnson C. D., Goodpasture E. W. 1934; An investigation of the etiology of mumps. J Exp Med 59:1–19 [View Article][PubMed]
    [Google Scholar]
14. Kauffman C. A., Bergman A. G., O’Connor R. P. 1982; Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression. Clin Exp Immunol 47:617–625[PubMed]
    [Google Scholar]
15. Kündig T. M., Hengartner H., Zinkernagel R. M. 1993; T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J Immunol 150:2316–2321[PubMed]
    [Google Scholar]
16. Lowen A. C., Mubareka S., Tumpey T. M., García-Sastre A., Palese P. 2006; The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A 103:9988–9992 [View Article][PubMed]
    [Google Scholar]
17. Maher J. A., DeStefano J. 2004; The ferret: an animal model to study influenza virus. Lab Anim (NY) 33:50–53 [View Article][PubMed]
    [Google Scholar]
18. Matsuoka Y., Lamirande E. W., Subbarao K. 2009; The ferret model for influenza. In Current Protocols in Microbiology Chapter 15, Unit 15G 12
    [Google Scholar]
19. Mehta P. D., Thormar H. 1979; Immunological studies of subacute measles encephalitis in ferrets: similarities to human subacute sclerosing panencephalitis. J Clin Microbiol 9:601–604[PubMed]
    [Google Scholar]
20. Nguyen D. T., Ludlow M., van Amerongen G., de Vries R. D., Yüksel S., Verburgh R. J., Osterhaus A. D., Duprex W. P., de Swart R. L. 2012; Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets. Vaccine 30:5073–5080 [View Article][PubMed]
    [Google Scholar]
21. Overman J. R. 1954; Antibody response of suckling mice to mumps virus. II. Relation of onset of antibody production to susceptibility to mumps virus infection. J Immunol 73:249–255[PubMed]
    [Google Scholar]
22. Park M. S., García-Sastre A., Cros J. F., Basler C. F., Palese P. 2003; Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77:9522–9532 [View Article][PubMed]
    [Google Scholar]
23. Patterson J. B., Thomis D. C., Hans S. L., Samuel C. E. 1995; Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210:508–511 [View Article][PubMed]
    [Google Scholar]
24. Pipkin P. A., Afzal M. A., Heath A. B., Minor P. D. 1999; Assay of humoral immunity to mumps virus. J Virol Methods 79:219–225 [View Article][PubMed]
    [Google Scholar]
25. Rubin S., Mauldin J., Chumakov K., Vanderzanden J., Iskow R., Carbone K. 2006; Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24:2662–2668 [View Article][PubMed]
    [Google Scholar]
26. Svitek N., von Messling V. 2007; Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 362:404–410 [View Article][PubMed]
    [Google Scholar]
27. Tokuda M. 1957; Studies on mumps virus. III. Experimental studies in guinea pigs. J Immunol 79:355–360[PubMed]
    [Google Scholar]
28. Tsurudome M., Yamada A., Hishiyama M., Ito Y. 1987; Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch Virol 97:167–179 [View Article][PubMed]
    [Google Scholar]
29. van der Veen J., Sonderkamp H. J. 1965; Secondary antibody response of guinea pigs to parainfluenza and mumps viruses. Arch Gesamte Virusforsch 15:721–734 [View Article][PubMed]
    [Google Scholar]
30. Wollstein M. 1916; An experimental study of parotitis (mumps). J Exp Med 23:353–375 [View Article][PubMed]
    [Google Scholar]
31. Zamanian-Daryoush M., Mogensen T. H., DiDonato J. A., Williams B. R. 2000; NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol 20:1278–1290 [View Article][PubMed]
    [Google Scholar]